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MHC. Resolving this question would
require identifying the predominant
non-MHC ligand(s) to which MHC-
independent T cells respond and show-
ing that they fail to respond to MHC+
targets when this ligand(s) is lacking.
Regardless of these unresolved is-
sues, this study demonstrates for the
first time that MHC-independent TCR
specificities can arise in vivo and pro-
vides a unique perspective on the role
of coreceptor molecules in thymic se-
lection, i.e., the concept that corecep-
tors might block the positive selection
of non-MHC-restricted TCRs by with-
olding access to Lck. Further work
will be required for the establishment
of the validity of this conceptually
elegant model.
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The regulatory T (Treg) cell transcriptional program is formed of distinct genetic networks that
respond to different activators. In this issue of Immunity, Hill et al. (2007) provide insights into the
interactions among the different networks and the overall role of Foxp3 in shaping the Treg cell
transcriptosome.The emergence of regulatory T (Treg)
cells as a T cell lineage dedicated
to the maintenance of immunological
tolerance has spurred efforts to iden-
tify the components of Treg cell tran-
scriptional circuits and elucidate their
higher-order organization. The driving
premise behind such a molecular ap-
proach is that it would help elucidate
how the Treg cell lineage develops
and by which means it attains and exer-
cises its regulatory functions. That Treg
cells are endowed with a distinct ge-
netic signature was rapidly established
by transcriptional profiling studies,
which revealed a reproducible set of
canonical transcripts that together
distinguish Treg from conventional T
(Tconv) cells (Fontenot et al., 2005b).
Interest in the Treg cell genetic signa-tures has been heightened by the iden-
tification of the transcription factor
Foxp3 as having attributes of a Treg
cell lineage commitment factor (Ziegler,
2006). Foxp3 confers regulatory prop-
erties upon its expression in Foxp3-de-
ficient Tconv cells, and it upregulates
the expression of many phenotypic
markers associated with the Treg cells.
Reciprocally, Foxp3 loss-of-function
mutations are associated with deficient
Treg cell function. Their occurrence
both in humans and in mice is associ-
ated with the onset of a lethal auto-
immune lymphoproliferative disease
that, at least in mice, can be amelio-
rated by the exogenous provision of
Treg cells. Thus, Foxp3 initially offered
the promise of an organizing principal
for the Treg cell transcriptosome.Immunity 27,Nevertheless, it has become clear
that Foxp3, although essential for
Treg cell-differentiated functions, does
not fulfill the role of a ‘‘master reg-
ulator’’ of the Treg cell transcripitional
programs. For one thing, a sizeable
portion of the Treg cell signature is
shared with activated T cells, whose
expression of Foxp3 is either low and
transient or altogether lacking, such
as in activated T cells that are Foxp3
deficient. Furthermore, the interleu-
kin-2 (IL-2) pathway, which plays a crit-
ical role in the maintenance of Treg
cells in the periphery, accounts for an-
other subset of the signature involved
in Treg cell fitness (Fontenot et al.,
2005a). Yet a third subset can be as-
cribed to the action of transforming
growth factor-beta (TGF-b) which,November 2007 ª2007 Elsevier Inc. 693
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development in the thymus, is vital to
the maintenance of Treg cells in the
periphery (Marie et al., 2005). TGF-b
also induces Foxp3 expression de novo
in Tconv cells in the context of T cell
receptor (TCR) and IL-2 signaling.
These cells are converted in the pro-
cess into induced or adaptive Treg
cells that share many of the attributes
of thymically derived or natural Treg
cells, indicative of a fundamental role
of TGF-b in shaping the Treg cell tran-
scriptosome (Chen et al., 2003).
Against this backdrop of diverse ac-
tivation pathways laying claim to por-
tions of the Treg cell genetic signature,
the role of Foxp3 in shaping the Treg
cell transcriptional landscape was re-
cently examined in studies on tagged
Foxp3 mutant alleles that are either
null or expressed an inactive Foxp3
mutant protein (Gavin et al., 2007; Lin
et al., 2007). In bothcases, Treg-related
cells develop in the thymus and are
present in the periphery. They express
most of the Treg cell genetic signa-
ture and phenotypic markers, including
a transcriptionally active Foxp3 locus,
but lack regulatory function. Foxp3
was confirmed to reinforce the expres-
sion of various components of the Treg
cell genetic signature and to restrain
Treg cells from degenerating into effec-
tor phenotypes. Nevertheless, these
studies establish that the acquisition
of most of the canonical components
of the Treg cell transcriptional program
proceeds independently of Foxp3,
suggesting that lineage determination
is further upstream of this factor.
The question of how the different
subcomponents of the Treg cell ge-
netic signature are organized and core-
gulated is addressed in the manuscript
by Hill et al. (2007) in this issue of
Immunity. The authors carefully teased
out the contribution of the diverse influ-
ences that shape the Treg cell genetic
signature: Foxp3 itself, IL-2, TGF-b,
and TCR signaling. What emerge are
coordinated interactions between the
different components of the Treg ge-
netic signature that reinforce each
other, forming reciprocating networks
that hold the signature together. A
case in point is the interaction between
TGF-b signaling and Foxp3. TGF-b in-
duces a subset of the Treg cell genetic694 Immunity 27, November 2007 ª2007signature (including Foxp3) in Tconv
cells in the context of TCR and IL-2 sig-
naling. Reciprocally, Foxp3 augments
the TGF-b response, reinforcing the lo-
calization of the TGF-b-regulated tran-
scription factors Smad2 and Smad3
in the nucleus and potentiating the
up- or downregulation of gene expres-
sion by TGF-b (Figure 1). As predicted
from earlier studies, Foxp3 itself in-
duces only a fraction of the Treg cell
genetic signature while reinforcing the
expression of components of the sig-
nature regulated by other activators
such as IL-2 and TGF-b.
Another insight from Hill et al. (2007)
centers on the component of the
Figure 1. Positive Reinforcement of
Foxp3 and TGF-b-Dependent Circuits
TGF-b signaling at its heterodimeric receptor
(TGF-bRI–TGF-bRII) results in the phosphory-
lation of the TGF-b-regulated transcriptional
activators Smad2 and Smad3 proteins, their
association with Smad4, and translocation to
the nucleus. Smad-dependent induction of
Foxp3 in turn reinforces TGF-b-dependent
gene expression, including the transcription
of TGF-bRI. A proposed mechanism involves
the promotion by Foxp3 of Smad protein
retention in the nucleus.Elsevier Inc.genetic signature that is not attributable
to Foxp3 or any of the aforementioned
pathways. The expression of some of
the constituent genes of this subset
strongly correlates with the expression
of Foxp3 itself, yet these were immune
to induction by a retrovirally transduced
Foxp3. This suggests that this gene
subset, including Foxp3 itself, might
represent a component of the Treg cell
signature controlled by genetic regula-
tor(s) upstream of Foxp3. Possible can-
didates include members of the Ikaros
family of transcription factors, which
may help shape Treg cell fate decisions
in the thymus. As pointed out by Hill
etal. (2007), it is likely thatacombination
of factors are involved in lineage com-
mitment, and their identification and
study will surely occupy the field for
some time to come. More difficult to de-
termine from this and other studies is
the nature of the suppressor mecha-
nism(s) endowed on Treg cells by
Foxp3. Functional studies have re-
vealed several candidate suppressor
mechanisms, including one that is de-
pendent oncell contact andcytotoxicity
and others that are dependent on
cytokine or cell-surface markers
(Miyara and Sakaguchi, 2007). How-
ever, gene-array studies have failed to
satisfactorycorrelate Treg cell suppres-
sor mechanisms with Foxp3 expres-
sion. Specifically, the expression of
components of these pathways such
as the granzymes and IL-10 persists
in the absence of a functional Foxp3,
suggesting the presence of additional
components or alternative pathways
through which Foxp3 enables suppres-
sion (Lin et al., 2007).
There are some limitations to the ex-
perimental approaches employed by
Hill et al. (2007). The dependence on
cell-surface markers such as CD25 to
identify Treg cells rather than tagged
Foxp3 alleles might have overweighed
the component of the Treg cell signa-
ture associated with T cell activation.
The TGF-b-regulated component of
the Treg cell genetic signature is
deduced from analysis of induced
Treg cells that lack suppressor activity,
raising questions about the complete-
ness of the gene-expression profile.
Their use may, arguably, have influ-
enced some of the conclusions con-
cerning the interactions among the
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Previewscomponents of the signature in a man-
ner different from what would have
been the case were thymically derived
Treg cells employed. Nevertheless,
and as pointed out by the authors, the
overlap between the genetic signatures
of induced and thymically derived Treg
cells suggests that a TGF-b-related
pathway is already functional in devel-
oping Treg cells in the thymus as well
asbeing operative in the periphery.Not-
withstanding these limitations, the find-
ings of Hill et al. (2007) still present us
with the clearest picture yet of how dis-
parate elements of the Treg cell signa-
ture integrate into one functional tran-
scriptosome. The reappraisal of the
role of Foxp3 from that of a Treg cell lin-
eage commitment factor to one more
involved in the Treg cell-differentiatedThe Toll of Too M
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Toll-like receptor 7 (TLR7) dete
leading to autoimmunity. Deane
risk of lupus in a mouse model.
The innate immune system not only
rapidly detects pathogens, but can
also distinguish (to some degree)
whether the pathogen is extracellular
or intracellular. The family of Toll-like
receptors (TLRs, ten of which are ex-
pressed in humans) is the best under-
stood of the innate immune receptors
that detect infections. Extracellular
pathogens appear to be detected by
cell-surface TLRs that recognize path-
ogen-expressed molecules such as
diacyl and triacyl lipopeptides and
lipopolysaccharides, in response to
which proinflammatory cytokines such
as TNF-a and IL-12 are secreted. In
contrast, the TLRs that detect intracel-
lular pathogens are expressed intracel-
lularly (in the endosomes and endoplas-
mic reticulum) and detect nucleic acids.functions and phenotype stability paves
the way toward identifying additional
factors influencing Treg cell develop-
ment and differentiated function. A
number of these, such as members of
the nuclear factor of activated T cells
(NFAT) and the acute myeloid leukemia
1-runt-related (Aml1/Runx) transcrip-
tion factor families, have already been
described and others are surely to
follow (Hu et al., 2007).
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The innate immune response to vi-
ruses and other intracellular patho-
gens depends critically on plasmacy-
toid dendritic cells (pDC), which are
highly specialized for producing large
amounts of type I interferon (IFN), re-
quired to control viral replication and
promote the development of a T helper
1 (Th1) response. Perhaps to avoid
their unnecessary activation by extra-
cellular bacteria, pDC do not express
any of the cell-surface TLRs—they
exclusively express the intracellular
TLR7, specific for RNA, and TLR9,
specific for unmethylated DNA. Thus,
pDC secretion of large amounts of
type I IFN can be triggered by either
DNA or RNA viruses.
Unfortunately for the host, endoge-
nous RNA and DNA are able to acti-
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d inappropriately by self-RNA,
dosage is directly related to the
vate TLR7 and TLR9 if the RNA enters
the endosomal compartment of the
pDC (or B cells, which also express
both of these TLRs). A rich potential
source of self-RNA and -DNA is the re-
mains of host cells that have died via
necrosis or apoptosis. Normally such
apoptotic debris appears to be cleared
rapidly by macrophages, which in hu-
mans do not express TLR7 or TLR9.
But if there is a delay in apoptotic
clearance, or if there are autoanti-
bodies reactive with the antigens ex-
posed on the apoptotic cells, then
these complexes can be misdirected
into pDC and B cells, where they can
activate TLR7 and/or TLR9 (Figure 1).
The result of this autoactivation is to
induce pDC secretion of type I IFN,
and if the B cell is activated through
November 2007 ª2007 Elsevier Inc. 695
